Wacker Biotech US

BiotechnologySeries BSan Diego, USwacker.com/biologics

Latest round

Series B

Last raised

Jun 2020

Total raised

$7.2M

Investors

1

About Wacker Biotech US

, operates as a biopharmaceutical company that offers contract development and manufacturing services for drugs and various treatments. In June 2020, Genopis Inc. Later In February 2021, Wacker Chemie agreed to acquire a full ownership stake in Genopis Inc. for USD 42 million.  The company offers a range of services, including molecular biology, process development, analytical development, and GMP manufacturing of biologics. The company engages in the biologics industry, providing services for the development and manufacturing of biopharmaceutical products and solutions for various sectors like pharmaceuticals and food additives.

Who invested in Wacker Biotech US

1 investor across 2 rounds

See all investors in Wacker Biotech US

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 15, 2020

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Sep 28, 2018

    Amount

    $7.2M

    Investors

    Locked

Questions about Wacker Biotech US

Who invested in Wacker Biotech US?

Wacker Biotech US has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Wacker Biotech US raised?

Wacker Biotech US has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Wacker Biotech US last raise money?

Wacker Biotech US's most recent round on record is a Series B, in Jun 2020.

What does Wacker Biotech US do?

, operates as a biopharmaceutical company that offers contract development and manufacturing services for drugs and various treatments.

Where is Wacker Biotech US headquartered?

Wacker Biotech US is headquartered in San Diego, US.

Which VCs invest in companies like Wacker Biotech US?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Wacker Biotech US's stage. Their profiles are linked below.

Raising like Wacker Biotech US? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.